Sensorion Announces SENS-601 Program Day Focused on GJB2 Gene Therapy for Hearing Loss

The Sept 22 event will spotlight the science behind Sensorion’s lead gene therapy candidate, the GJB2-related hearing loss patient population, and the design of the HearConnex clinical trial. Sensorion, a clinical-stage biotechnology company focused on developing therapies to restore and treat hearing loss, has announced registration and connection details for its SENS-601 Program Day, scheduled for Sept 22, 2026....

Continue reading at Hearing Review

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — this is a pre-trial program announcement; SENS-601 has not yet demonstrated clinical efficacy in humans.

✦ Why It Matters ✦

GJB2-related hearing loss is the most prevalent form of genetic hearing loss, and a successful gene therapy could eventually offer a biological treatment alternative to hearing aids and cochlear implants for this population.

✦ Key Points ✦

01Sensorion is hosting a Sept. 22 program day focused on its SENS-601 GJB2 gene therapy candidate.
02GJB2 gene mutations are among the most common genetic causes of congenital (present-at-birth) hearing loss.
03The event will outline the design of the HearConnex clinical trial for SENS-601.
04SENS-601 is still in the pre-clinical/early clinical stage — no human efficacy data have been released.
05This announcement is an investor/stakeholder communications event, not a data readout.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

SENS-601 is a gene therapy candidate targeting GJB2-related hearing loss.

press releaseunclear

Sensorion will present the design of the HearConnex clinical trial at the Sept. 22 event.

press releasesupported

✦ Related stories ✦

PubMed·Journal article·Research (general)·2mo ago

Impaired speech-in-noise perception in individuals with a history of hearing symptoms after noise exposure

Audiologists should consider supplementing standard audiograms with speech-in-noise testing for patients reporting noise-exposure symptoms, as normal thresholds alone may miss clinically meaningful hearing dysfunction consistent with cochlear synaptopathy (hidden hearing loss).

PubMed·Journal article·Research (general)·3mo ago

Effects of Hearing Intervention on Cognitive Function in Patients with Presbycusis: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis provides the strongest available evidence that hearing intervention positively impacts cognitive function in older adults with age-related hearing loss; audiologists should use these findings to counsel patients and reinforce the...

PubMed·Journal article·Research (general)·3mo ago

The Genetic Causes of Auditory Neuropathy: A Systematic Review

Genetic testing for auditory neuropathy is clinically meaningful because the causative gene can influence cochlear implant candidacy and expected outcomes; audiologists should advocate for genetic workup in confirmed auditory neuropathy cases.

PubMed·Journal article·Research (general)·3mo ago

Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis

Audiologists should consider routine hearing screening for adult patients with known diabetes or prediabetes, as this meta-analysis provides strong epidemiological evidence linking both conditions to increased prevalence and severity of hearing loss.

PubMed·Journal article·Research (general)·3d ago

Increased listening effort and decreased speech perception at high presentation sound levels in older hearing-impaired adult listeners

Audiologists should avoid assuming that higher presentation levels always benefit older hearing-impaired listeners; fitting and counselling protocols should account for the paradoxical degradation in speech perception and increased listening effort at high levels.

PubMed·Clinical trial·Research (general)·7d ago

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

are secondary and exploratory — audiologists should not change practice based on these biomarker findings alone, but the study adds biological plausibility to hearing intervention as a potential tool for brain health preservation.

PubMed·Preprint·Research (general)·2mo ago

Older adults show overexaggerated and larger noise-related degradation in their neural tracking of speech

This finding suggests age-related declines in how the brain tracks speech in noise go beyond peripheral hearing loss; audiologists should be cautious attributing all speech-in-noise difficulty in older adults to the audiogram alone, though the preprint has not yet been...

PubMed·Journal article·Research (general)·2mo ago

ATP6V1B1-A Novel Genetic Association Between Pendred Imaging Phenotype and Renal Tubular Acidosis

Audiologists and otolaryngologists encountering patients with the Pendred imaging phenotype (enlarged vestibular aqueduct/cochlear malformation pattern) should consider ATP6V1B1 mutation testing and prompt referral for renal evaluation, as co-existing distal renal tubular...